Sandeep Kulkarni
Director/Board Member chez ZURA BIO LIMITED
Fortune : 17 M $ au 31/03/2024
Profil
Sandeep D.
Kulkarni founded Tourmaline Bio LLC in 2021, where he is working as Chief Executive Officer from 2021, Tourmaline Sub, Inc. in 2021, where he is working as Chief Executive Officer & Director from 2021, and Tourmaline Bio, Inc. in 2021, where he is working as Chief Executive Officer & Director from 2021.
Dr. Kulkarni also currently works at Zura Bio Ltd., as Independent Director from 2022.
Dr. Kulkarni also formerly worked at KVP Capital Advisors LP, as Managing Director from 2020 to 2022, QVT Financial LP, as Investment Analyst from 2013 to 2017, The Boston Consulting Group, Inc., as Consultant from 2009 to 2012, Consonance Capital Management LP, as Senior Analyst, and Immunovant, Inc., as Chief Operating Officer from 2018 to 2020.
Dr. Kulkarni received his doctorate degree from The University of California, San Francisco and undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
2,85% | 17/11/2023 | 729 735 ( 2,85% ) | 17 M $ | 31/03/2024 |
Postes actifs de Sandeep Kulkarni
| Sociétés | Poste | Début |
|---|---|---|
| ZURA BIO LIMITED | Director/Board Member | 01/03/2022 |
| Tourmaline Bio LLC | Chief Executive Officer | 01/09/2021 |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The private company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Founder | 01/09/2021 |
Anciens postes connus de Sandeep Kulkarni
| Sociétés | Poste | Fin |
|---|---|---|
KVP Capital Advisors LP
 KVP Capital Advisors LP Investment ManagersFinance KVP Capital Advisors LP provides investment advice. The private company is based in San Francisco, CA. | Corporate Officer/Principal | 01/06/2022 |
| IMMUNOVANT, INC. | Chief Operating Officer | 01/06/2020 |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Analyst-Equity | 01/08/2017 |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/05/2012 |
Consonance Capital Management LP
 Consonance Capital Management LP Investment ManagersFinance Consonance Capital Management LP (Consonance Capital) is a hedge fund firm headquartered in New York City. The firm was founded in 2007 by Mitchell Blutt, Kevin Livingston, and Benny Soffer. They are a subsidiary of Consonance Capman GP LLC. Consonance Capital provides investment advisory services to private pooled investment vehicles. | Analyst-Equity | - |
Formation de Sandeep Kulkarni
| The University of California, San Francisco | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| Entreprise privées | 6 |
|---|---|
QVT Financial LP
QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Finance |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Consonance Capital Management LP
Consonance Capital Management LP Investment ManagersFinance Consonance Capital Management LP (Consonance Capital) is a hedge fund firm headquartered in New York City. The firm was founded in 2007 by Mitchell Blutt, Kevin Livingston, and Benny Soffer. They are a subsidiary of Consonance Capman GP LLC. Consonance Capital provides investment advisory services to private pooled investment vehicles. | Finance |
KVP Capital Advisors LP
KVP Capital Advisors LP Investment ManagersFinance KVP Capital Advisors LP provides investment advice. The private company is based in San Francisco, CA. | Finance |
| Tourmaline Bio LLC | |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The private company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Commercial Services |
